NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) announced today the filing by Black Titan Corporation with the U.S. Securities and Exchange Commission (“SEC”) of a registration statement on Form F-4 in connection with the proposed combination of Titan and TalenTec Sdn. Bhd. (f/k/a KE Sdn. Bhd.)
Long before SPACs became a big hit on Wall St. there were “ordinary” Reverse Mergers on the Nasdaq & NYSE with small operating companies that no longer had a need to be public.
Read MoreSo before we begin let’s start by defining a few key terms: 1. S-1 is a registration statement filing that gets submitted for examination and final approval by the SEC. Once approved the company can raise money based upon the terms set forth within the S-1 (i.e.) minimum/maximum of…
Read More